Cardiovascular Risk Early Screening and Warning in Harbin : A Prospective Cohort Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

10000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-07-01

Study Completion Date

2047-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this prospective cohort study is to collect the multi-omics profile of cardiovascular disease (CVD) high-risk individuals in Harbin, and to discover novel biomarker signatures of major adverse cardiovascular events (MACE) during a minimum 2-year follow-up period.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Incidence Rate of Heart Failure After Acute Myocardial Infarction With Optimal Treatment

NCT03297164

Acute Myocardial Infarction Heart Failure

COMPLETED

Early Warning and Classification Model for Acute Non-traumatic Chest Pain

NCT06196307

Chest Pain

RECRUITING

Risk Prediction of Disease Progression in Early-Onset Coronary Atherosclerosis

NCT07316452

Coronary Disease Young Adult

RECRUITING

Prospective Coronary Heart Disease Cohort

NCT05699629

Coronary Heart Disease Myocardial Infarction

RECRUITING

Correlation of Biomarkers With the Presence and Severity of Coronary Artery Disease

NCT05015270

Coronary Artery Disease

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a single-center, observational, prospective cohort study. The primary endpoint is the incidence of MACE. Participants must meet at least two of the following criteria: hypertension, hyperglycemia, hyperlipidemia, or obesity. Baseline data and biological samples will be collected at enrollment, with clinical outcomes monitored for a minimum of two years. The study aims to enroll 10,000 participants aged 45 years and older from Harbin city, located in northeastern China.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiovascular Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 1.Residents of Harbin city, regardless of gender.
* 2.Meets at least two of the following conditions: diabetes, hypertension, hyperlipidemia, or obesity.
* 3.No history of cardiovascular or cerebrovascular diseases.
* 4.Willing to participate in the study and sign the informed consent form

Exclusion Criteria

* 1.History of antibiotic or probiotic treatment within the past month.
* 2\. Pregnant women.
* 3\. History of autoimmune diseases or malignant tumors; severe heart, liver, or kidney dysfunction; or a history of severe cardiovascular or cerebrovascular diseases.
* 4\. Any unstable condition or situation that may jeopardize patient safety or compliance.
* 5\. Patients unable to provide informed consent due to physical reasons or unwilling to participate.

Minimum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No